<b>Background:</b> Many studies evaluating central nervous system (CNS) metastases in breast cancer (BC) combine germline <i>BRCA1</i> and <i>BRCA2</i> pathogenic variant carriers, limiting gene-specific interpretation. The gene discussed is BRCA2; the disease is breast cancer.